High live birth rate after conservative treatment of ectopic pregnancy with Methotrexate
Wysoka częstość żywych urodzeń po zachowawczym leczeniu ciąż ektopowych Metotreksatem
-DNXE:\URED-y]HI.U]\VLHN$JQLHV]ND5DMWDU&LRVHN2OJD.DFDOVND-DQVVHQ$QGU]HM
=PDF]\ĔVNL-RDQQD:LDWU7RPDV]0LOHZLF]0DJGDOHQD3XOND
Department of Gynecological EndocrinologyJagiellonian University Medical College, Krakow, Poland
Abstract
Objectives: The aim of the study was to assess fertility in patients diagnosed with ectopic pregnancy and treated with methotrexate, as well as safety and efficacy of conservative treatment. Also, risk factors of recurrent ectopic pregnancies were determined.
Material and methods: The study included 86 female patients with ectopic pregnancy, hospitalized and treated in the clinic of Gynecological Endocrinology, UJCM, Cracow, between 2007 and 2011. A total of 73 patients received a single dose of MTX in the amount of 50mg/m2 of body surface area. Serum b-hCG concentration was measured on days 4 and 7. The treatment was considered successful when b-hCG concentrations dropped to less than 0.2mIU/ml without surgery.
Results: Among 34 patients on follow-up, 8 (23.5%) did not attempt to conceive again, whereas 26 patients declared their wish to conceive again. The attempt proved to be successful in case of 16 women (61.53%), and they gave birth to healthy children. Average time to pregnancy was 14.9 months (SD±10.9). The first pregnancy occurred after 6 months and the last after 35 months. No congenital birth defects were found in the newborns.
Conclusions: Systemic, conservative treatment with methotrexate is an effective and safe way of managing ectopic pregnancy, even in cases with higher b-hCG concentrations. Most patients can be successfully treated without surgery, thus they may even be treated in outpatient settings. High fertility can be maintained and is independent of the skills of the operators and access to laparoscopic techniques. Conservative treatment does not increase the risk of recurrent ectopic pregnancy but should be offered in wards that provide 24-hour surgical care.
Key words: HFWRSLFSUHJQDQF\/ PHWKRWUH[DWH / IHUWLOLW\ / FRQVHUYDWLYH WUHDWPHQW /
Otrzymano: 20.05.2013
Zaakceptowano do druku: 30.10.2013 Corresponding author:
Jakub Wyroba
Department of Gynecological Endocrinology Jagiellonian University Medical College, Ul. Kopernika 23, 31-501 Kraków, Poland Tel 12-424-85-71; Fax. 12-424-85-70 email: kuba4u@gmail.com
Introduction
7KHIUHTXHQF\RIHFWRSLFSUHJQDQFLHVKDVEHHQRQWKHULVH
The Center for Disease Control and Prevention &'&HVWLPDWHG
WKDWLQRIDOOSUHJQDQFLHVZHUHHFWRSLF&XUUHQWO\
&'& UHSRUWV WKH SHUFHQWDJH WR KDYH ULVHQ WR >@
)XUWKHUPRUHWKH\UHSRUWDIROGLQFUHDVHLQHFWRSLFSUHJQDQFLHV
IURPFDVHVLQWRFDVHVLQUHODWHGWR
ZLGHVSUHDG DFFHVV WR DVVLVWHG UHSURGXFWLYH WHFKQRORJLHV $57
>@ JUHDWHU SUHYDOHQFH RI VH[XDOO\ WUDQVPLWWHG GLVHDVHV DQG
LQFUHDVHGLQFLGHQFHRISHOYLFLQÀDPPDWRU\GLVHDVHV3,'>@
±HVSHFLDOO\GXHWR&hlamydia trachomatisLQIHFWLRQV>@
8QWLO WKH HQG RI WKH V ODSDURVFRS\ KDV UHPDLQHG WKH
PDLQ GLDJQRVWLF WRRO IRU HFWRSLF SUHJQDQF\ ,Q WKH ODVW GHFDGH
WKHGHYHORSPHQWRIXOWUDVRQRJUDSK\KDVDOORZHGLPSURYHPHQWV
LQ WKH GLDJQRVLV ZLWK VXI¿FLHQW VHQVLWLYLW\ DQG VSHFL¿FLW\ RI
LQFRUUHFWO\LPSODQWHGHPEU\RV7KHVHQVLWLYLW\DQGVSHFL¿FLW\RI
DVLQJOHWUDQVYDJLQDOXOWUDVRQRJUDSK\WHVW796DUH
&, ± DQG &, ± UHVSHFWLYHO\
>@,WLVHVWLPDWHGWKDWRIHFWRSLFSUHJQDQFLHVDSSHDUDVD
KHWHURJHQHRXVPDVVDGMDFHQWWRWKHRYDU\±Dµblob sign’
DVDQDUHDZLWKDK\SHUHFKRJHQLFULQJ±Dµbagel sign’DQG
DVDJHVWDWLRQDOVDFFRQWDLQLQJDIHWDOSROHZLWKSUHVHQWRUDEVHQW
KHDUWDFWLYLW\796LVWKHJROGVWDQGDUGLQWKHHDUO\GLDJQRVLVRI
DQ\ W\SH RI HFWRSLF SUHJQDQF\ ZKHUHDV ODSDURVFRS\ RQO\ KDV
DUROHLQFDVHRIWUHDWPHQWLQWHUYHQWLRQ>@7KHUHDOVRH[LVWVD
VPDOO JURXS RI ZRPHQ ZLWK D SRVLWLYH SUHJQDQF\ WHVW DQG DQ
XQFKDUDFWHULVWLFLPDJHLQ796WHVWLQJGHVFULEHGLQWKHOLWHUDWXUH
DV38/3UHJQDQF\RI8QNQRZQ/RFDWLRQ
7KH VHFRQG HVVHQWLDO IDFWRU LQ GLDJQRVLQJ DQ HFWRSLF
SUHJQDQF\LVWKHFRQFHQWUDWLRQRIKXPDQFKRULRQLFJRQDGRWURSLQ
K&*LQWKHEORRGVHUXP,QWKHVWKHUHZDVDQLPSURYHPHQW
LQWKHPHWKRGXVHGWRGHWHUPLQHWKHEK&*VXEXQLWLQXULQHDV
ORZDVP,8POZKLFKDOORZHGIRUWKLVPHWKRGWREHXVHGLQ
WKHHDUO\GLDJQRVLVRIHFWRSLFSUHJQDQF\>@
3UHVHQWO\ XVHG LPPXQRHQ]\PDWLF (/,6$ PHWKRGV FDQ
VKRZEK&*OHYHOVRIP,8POLQWKHEORRGVHUXPZLWKLQRQH
KRXU$GGLWLRQDOO\LQDVHULHVRIWHVWVDVORZHULQFUHDVHLQEK&*
LQWKHEORRGVHUXPLVREVHUYHGLQFDVHVRIHFWRSLFSUHJQDQFLHV
FRPSDUHG WR WKH SK\VLRORJLFDO GRXEOLQJ ZLWKLQ KRXUV LQ
HXWRSLF SUHJQDQFLHV7KH ULVN IRU DQ HFWRSLF SUHJQDQF\ LV KLJK
LIWKHREVHUYHGLQFUHDVHRIWKHYDOXHLVOHVVWKDQ7KHXVHRI
WKHGLDJQRVWLFPHWKRGRILQFUHDVLQJEK&*OHYHOVDORQHUHVXOWV
LQRIHFWRSLFSUHJQDQFLHVEHLQJXQGLDJQRVHG0RUHRYHUD
ORZHUWKDQH[SHFWHGULVHLQEK&*OHYHOVPD\DOVREHREVHUYHG
LQRIQRUPDOSUHJQDQFLHV>@3UHVHQWO\HDUO\GLDJQRVLVRI
HFWRSLF SUHJQDQF\ LV EDVHG RQ FRPELQLQJ WKH 796 HYDOXDWLRQ
ZLWKVHUXPEK&*FRQFHQWUDWLRQ
6LQFHZKHQWKH¿UVWRSHUDWLRQGXHWRLQWUDDEGRPLQDO
KHPRUUKDJHFDXVHGE\DQHFWRSLFSUHJQDQF\ZDVSHUIRUPHG>@
ODSDURVFRSLFWHFKQLTXHVKDYHVWDUWHGWRUHSODFHODSDURWRP\DQG
EHFRPHDQHVVHQWLDOSDUWRIWKHWUHDWPHQW6LPXOWDQHRXVO\LQ
&KRWLQHUZDVWKH¿UVWWRUHSRUWDVXFFHVVIXOWUHDWPHQWRIDIDOORSLDQ
WXEH SUHJQDQF\ XVLQJ PHWKRWUH[DWH 07; >@ EHJLQQLQJ
DQ HUD RI FRQVHUYDWLYH PDQDJHPHQW 0HWKRWUH[DWH D IROLF DFLG
DQWDJRQLVW GLVUXSWV SURSHU '1$ V\QWKHVLV WKXV LQKLELWLQJ FHOO
SUROLIHUDWLRQ 7URSKREODVWLF WLVVXH LV HVSHFLDOO\ VHQVLWLYH WR WKH
HIIHFW RI WKLV F\WRVWDWLF GUXJ :LWK UHJDUG WR LWV PHFKDQLVP RI
DFWLRQLWLVLPSRUWDQWWRQRWHVWURQJDQWLLQÀDPPDWRU\SURSHUWLHV
>@RI07;ZKLFKPD\KDYHDSRVLWLYHLQÀXHQFHRQLPSURYLQJ
IHUWLOLW\LQWKHIXWXUH9DULRXVVFKHPHVRIFRQVHUYDWLYHWUHDWPHQW
DUH XVHG 'XH WR KLJK FRVWV RI KRVSLWDOL]DWLRQ D EHQH¿W ZDV
GHPRQVWUDWHG LQ SDWLHQWV ZLWK FRQVHUYDWLYH 07; WUHDWPHQW LQ
D VFKHPH RI PXOWLSOH GRVHV ZKHUH EK&* FRQFHQWUDWLRQV ZHUH
P,8PO >@ ,Q FRQWUDVW WR WKLV VFKHPH DSSOLFDWLRQ RI
DVLQJOHGRVHLQWKHDPRXQWRIPJPRIERG\VXUIDFHDUHD
FRQWULEXWHG WR WKH UHGXFWLRQ RI WUHDWPHQW FRVWV E\ VKRUWHQLQJ
WKH GXUDWLRQ RI KRVSLWDOL]DWLRQ ZKLFK DOVR MXVWL¿HV WKH XVH RI
FRQVHUYDWLYHWUHDWPHQWLQKLJKHUEK&*FRQFHQWUDWLRQV6SHFLDO
Streszczenie
Cel pracy: Badanie miało na celu ocenę płodności pacjentek ze zdiagnozowaną ciążą pozamaciczną leczonych metotreksatem, skuteczność i bezpieczeństwo leczenia zachowawczego oraz poszukiwanie czynników ryzyka powtórnej ciąży pozamacicznej.
Materiał i metody: 86 pacjentek ze zdiagnozowaną ciążą pozamaciczną było objętych leczeniem w Klinice Endokrynologii Ginekologicznej UJCM w Krakowie od 2007 do 2011 roku. Po zakwalifikowaniu u 73 pacjentek zastosowano terapię pojedynczej dawki metotreksatu w ilości 50 mg/m2 powierzchni ciała. Kolejno oceniano stężenia b-hCG w surowicy krwi w dniu czwartym i siódmym terapii. Za sukces terapeutyczny uznawano obniżenie wartości b-hCG poniżej 0,2 mIU/ml bez konieczności wykonania zabiegu operacyjnego.
Wyniki: Pośród 34 pacjentek z przebywających w opiece przyklinicznej, 8 (23,5%) nie zdecydowało się na kolejną ciążę. 26 pacjentek zdeklarowało plany reprodukcyjne, 16 (61,53%) z nich urodziło zdrowe dzieci. Średni czas do uzyskania ciąży wynosił 14,9 (SD 10,9) miesiąca. Pierwsza ciąża wystąpiła po 6 miesiącach a ostatnia obserwowana po 35 miesiącach. Nie zaobserwowano żadnych wad wrodzonych u urodzonych dzieci.
Wnioski: Systemowe leczenie zachowawcze metotreksatem jest terapią skuteczną i bezpieczną nawet przy wyższych wartościach b-hCG niż 3500 mIU/ml. Umożliwia wyleczenie większości pacjentek bez konieczności wykonywania zabiegu operacyjnego, nawet w trybie ambulatoryjnym. Pozwala na utrzymanie wysokiej płodności niezależnie od umiejętności operatora i dostępności technik laparoskopowych. Leczenie zachowawcze nie zwiększa ryzyka rozwoju ponownie ciąży pozamacicznej.
Słowa kluczowe: FLąĪD HNWRSRZD / PHWRWUHNVDW / SáRGQRĞü / leczenie zachowawcze /
DWWHQWLRQLVJLYHQWRWKHIDFWWKDWWKHWUHDWPHQWPD\EHXVHGLQ
RXWSDWLHQWSUDFWLFHV>@07;JLYHQORFDOO\ERWKXQGHU796DV
ZHOODVODSDURVFRSLFFRQWURO>@GLGQRWGHPRQVWUDWHVLJQL¿FDQW
GLIIHUHQFHV DV FRPSDUHG WR LQWUDPXVFXODU DGPLQLVWUDWLRQ 7KH
DGYDQWDJHV RI V\VWHPLF DGPLQLVWUDWLRQ LQFOXGH VLPSOLFLW\ RI
WKHUDS\LQGHSHQGHQFHRIWKHVNLOOVRIWKHRSHUDWRUDVZHOODVWKH
SRVVLELOLW\RIWUHDWPHQWLQRXWSDWLHQWVHWWLQJV
$QHJDWLYHHIIHFWRQIHUWLOLW\GXHWR07;WUHDWPHQWKDVQRW
EHHQ REVHUYHG > @ 0RUH LPSRUWDQWO\ QR QHJDWLYH
HIIHFW RQ WKH RYDULDQ UHVHUYH KDV EHHQ QRWHG HLWKHU >@ 7KH
PRVW FRPPRQ HWLRORJ\ RI HFWRSLF SUHJQDQF\ LV FRQVLGHUHG WR
EH WKH FOLQLFDO RU VXEFOLQLFDO LQÀDPPDWLRQ RI WKH IDOORSLDQ
WXEHV SRVVLEO\ OHDGLQJ WR LUUHYHUVLEOH DQG ELODWHUDO GDPDJH
RI WKHLU IXQFWLRQ &RQVHTXHQWO\ WKLV UHVXOWV LQ UHFXUUHQFHV RI
LQFRUUHFWO\ LPSODQWHG SUHJQDQFLHV RU GLI¿FXOWLHV WR FRQFHLYH
>@&RQVHUYDWLYHWUHDWPHQWZLWK07;GXHWRLWVVWURQJDQWL
LQÀDPPDWRU\SURSHUWLHVPD\SRVLWLYHO\LQÀXHQFHWKHIXQFWLRQRI
WKHRSSRVLWHIDOORSLDQWXEHWKXVFRQWULEXWLQJWRLPSURYLQJIXUWKHU
SURFUHDWLRQ
7KH WLPH SHULRG RI FRPSOHWH H[FUHWLRQ RI 07; IURP WKH
ERG\LV±PRQWKV>@7KHIDFWWKDW07;WKHUDS\LVVDIH
IRU IXWXUH RIIVSULQJ LV SDUWLFXODUO\ QRWHZRUWK\ ,Q UHWURVSHFWLYH
VWXGLHVQRGLIIHUHQFHVZHUHGHPRQVWUDWHGLQWKHIUHTXHQFLHVRI
IHWDO GHIHFWV EHWZHHQ SDWLHQWV ZKR FRQFHLYHG ZLWKLQ PRQWKV
6' LQWRWKH07;WUHDWPHQWDVFRPSDUHGWRWKRVHZKR
FRQFHLYHGDIWHUDORQJHUSHULRGRIWLPH6' >@7KH
ULVNZDVHTXDOWRWKDWRIWKHJHQHUDOSRSXODWLRQ
Objectives
7KHDLPVRIWKHVWXG\ZHUHWRHYDOXDWHIHUWLOLW\RISDWLHQWV
GLDJQRVHGZLWKDQHFWRSLFSUHJQDQF\DQGWUHDWHGZLWK07;WR
DVVHVVWKHVDIHW\DQGHI¿FDF\RIFRQVHUYDWLYHWUHDWPHQWDQGWR
GHWHUPLQHWKHULVNIDFWRUVRIUHFXUUHQWHFWRSLFSUHJQDQFLHV
Material and methods
$ WRWDO RI IHPDOH SDWLHQWV GLDJQRVHG ZLWK DQ HFWRSLF
SUHJQDQF\ ZHUH KRVSLWDOL]HG DQG WUHDWHG LQ WKH FOLQLF RI
*\QHFRORJLFDO (QGRFULQRORJ\ 8-&0 &UDFRZ EHWZHHQ
DQG 7KH GLDJQRVLV ZDV HVWDEOLVKHG RQ WKH EDVLV RI DQ
DEQRUPDOLQFUHDVHLQEK&*FRQFHQWUDWLRQVDQGXOWUDVRQRJUDSKLF
796 FRQ¿UPDWLRQ RI FKDQJHV LQ WKH SDUDRYDULDQ UHJLRQ ZLWK
WKHDLGRIWKH*(9ROXVRQ([SHUWRURQWKHEDVLVRIEK&*
!P,8PODQGDEVHQFHRIDJHVWDWLRQDOVDFLQWKHXWHULQH
FDYLW\
$PRQJWKHSDWLHQWVZKRZHUHTXDOL¿HGIRUFRQVHUYDWLYH
07;WUHDWPHQWQRQHRIWKHSUHJQDQFLHVGLVSOD\HGVLJQVRIIHWDO
FDUGLDFDFWLYLW\RUVLJQVRIDFWLYHKHPRUUKDJHLQWRWKHDEGRPLQDO
FDYLW\ ([FOXGLQJ FULWHULD ZHUH KHPRG\QDPLF LQVWDELOLW\ VLJQV
RI SHULWRQLWLV KHWHURWRSLF SUHJQDQF\ FRQWUDLQGLFDWLRQV WR
DGPLQLVWHULQJPHWKRWUH[DWHHJOHXNRSHQLDWKURPERF\WRSHQLD
HOHYDWHG OLYHU HQ]\PHV RU ELRFKHPLFDO LQGLFDWRUV RI UHQDO
LQVXI¿FLHQF\$IWHUREWDLQLQJZULWWHQFRQVHQWIRUWKHSURSRVHG
WUHDWPHQW SODQ WKH SDWLHQWV UHFHLYHG D VLQJOH GRVH RI 07; LQ
WKH DPRXQW RI PJP RI ERG\ VXUIDFH DUHD 6XEVHTXHQWO\
VHUXP EK&* FRQFHQWUDWLRQ ZDV PHDVXUHG RQ GD\V DQG
DIWHUWKH¿UVWGRVH$OVREORRGPRUSKRORJ\DQGOLYHUHQ]\PHV
ZHUHPRQLWRUHG,IDGHFUHDVHRIDWOHDVWRIWKHPD[LPXP
EK&*YDOXHZDVREVHUYHGWKHSDWLHQWZDVGLVFKDUJHGIURPWKH
ZDUGDQGLQVWUXFWHGWRPRQLWRUEK&*FRQFHQWUDWLRQVZHHNO\DW
WKHRXWSDWLHQWFOLQLFDQGWRXQGHUJR796WHVWLQJXQWLOFRPSOHWH
GLVDSSHDUDQFHRIEK&*$IWHUWKHFRPSOHWLRQRIWKHUDS\2&3
ZDVUHFRPPHQGHGIRUDSHULRGRIPRQWKVDQGWHOHSKRQHFRQWDFW
ZLWKWKHSULPDU\FDUHSK\VLFLDQZDVHQVXUHG)XUWKHUPRUHIROLF
DFLGVXSSOHPHQWDWLRQLQSURSK\ODFWLFGRVDJHZDVDGGHGLQSDWLHQWV
ZKRGLGDVZHOODVGLGQRWLQWHQGWRFRQFHLYHLQWKHIXWXUH
7KHQH[WGRVHRI07;ZDVDGPLQLVWHUHGWRWKRVHSDWLHQWV
LQ ZKRP EK&* FRQFHQWUDWLRQV GHFUHDVHG E\ OHVV WKDQ
UHPDLQHG FRQVWDQW RU LQFUHDVHG EHWZHHQ GD\V DQG DIWHU
LQLWLDWLQJ WKH ¿UVW GRVH 6XEVHTXHQW GRVHV ZHUH DGPLQLVWHUHG
XQWLO D VDWLVIDFWRU\ GHFUHDVH LQ VHUXP EK&* FRQFHQWUDWLRQ
ZDV REWDLQHG RU VLJQV RI DGYHUVH HIIHFWV GXH WR WKH PHGLFDWLRQ
DSSHDUHG 7KH PD[LPDO GRVH RI 07; ZDV PJ WKURXJKRXW
WKH FRXUVH RI WKH WUHDWPHQW DQG WKH WUHDWPHQW UHJLPHQ ZDV LQ
FRPSOLDQFH ZLWK WKH JXLGHOLQHV IRU LQLWLDWLQJ DQG ZLWKGUDZLQJ
WKHPHGLFDWLRQ3DWLHQWVZHUHLQVWUXFWHGWRDWWHQGUHJXODUIROORZ
XSYLVLWVDWWKHRXWSDWLHQWFOLQLFDQGPRQWKVDIWHU
WUHDWPHQW FRPSOHWLRQ HVSHFLDOO\ LQ FDVHV ZKHQ WKH\ ZLVKHG WR
FRQFHLYHDJDLQ
7KH WUHDWPHQW ZDV FRQVLGHUHG VXFFHVVIXO ZKHQ EK&*
FRQFHQWUDWLRQV GURSSHG WR OHVV WKDQ P,8PO DIWHU LQLWLDWLQJ
FRQVHUYDWLYHWKHUDS\ZLWKRXWWKHQHHGRIVXUJLFDOLQWHUYHQWLRQ
,QFDVHVRIREVHUYDWLRQORVVLHWKHSDWLHQWGLGQRWDSSHDU
DWWKHRXWSDWLHQWFOLQLFDQGPRQWKVDIWHUWUHDWPHQW
FRPSOHWLRQ WHOHSKRQH FRQWDFW ZDV PDGH LQ RUGHU WR GHWHUPLQH
WKHLUSURFUHDWLYHVWDWXV
6WDWLVWLFDO DQDO\VHV ZHUH FRQGXFWHG ZLWK 67$7,67,&$
7KH 6KDSLUR:LON WHVW ZDV XVHG IRU WKH DQDO\VLV RI QRUPDOO\
GLVWULEXWLRQ YDULDEOHV 0HDQV PHGLDQ VWDQGDUG GHYLDWLRQV DV
ZHOO DV PLQLPXP DQG PD[LPXP YDOXHV ZHUH FDOFXODWHG IRU
FRQWLQXRXV GDWD 7KH 0DQQ:KLWQH\ WHVW ZDV XVHG IRU JURXS
FRPSDULVRQV RI FRQWLQXRXV YDULDEOHV 7KH FKLVTXDUH WHVW IRU
LQGHSHQGHQFH ZDV XVHG IRU JURXS FRPSDULVRQV RI FDWHJRULFDO
YDULDEOHVpZDVFRQVLGHUHGDVVWDWLVWLFDOO\VLJQL¿FDQW
Results
$ WRWDO RI SDWLHQWV SDUWLFLSDWHG LQ WKH VWXG\ DQG DIWHU
IXO¿OOLQJ WKH FULWHULD IRU LQLWLDWLQJ DQG ZLWKGUDZLQJ 07;
SDWLHQWVTXDOL¿HGIRUFRQVHUYDWLYHWUHDWPHQWSDWLHQWV
TXDOL¿HGIRUWKHVXUJLFDOWUHDWPHQWDQGLQSDWLHQW WKHWUHDWPHQWZDVREVHUYDWLRQDO'HVSLWHFRQVHUYDWLYHWUHDWPHQW
LQWUDDEGRPLQDOKHPRUUKDJHRFFXUUHGLQSDWLHQWVGXULQJ
KRVSLWDOL]DWLRQDQGVXUJLFDOLQWHUYHQWLRQZDVUHTXLUHG7KHIDFW
WKDWWKHUHZDVRQO\RQHFDVHRIIDOORSLDQWXEHSHUIRUDWLRQGXULQJ
WKHVXUJLFDOLQWHUYHQWLRQLVSDUWLFXODUO\QRWHZRUWK\
7KHDYHUDJHOHQJWKRIKRVSLWDOL]DWLRQLQSDWLHQWVXQGHUJRLQJ
FRQVHUYDWLYH WUHDWPHQW ZDV GD\V 6' 7KH DYHUDJH
FRQFHQWUDWLRQ RI EK&* XSRQ DGPLVVLRQ ZDV P,8
PO 6' ZLWK D PD[LPXP EK&* FRQFHQWUDWLRQ RI
P,8PO 6' 8SRQ GLVFKDUJH WKH DYHUDJH
FRQFHQWUDWLRQ RI EK&* ZDV P,8PO 6'
LQGLFDWLQJDGHFUHDVHRIEK&*E\6'LQUHODWLRQ
WR WKH PD[LPDO YDOXHV GXULQJ KRVSLWDOL]DWLRQ ,Q WKH PDMRULW\
RI SDWLHQWV LQWUDPXVFXODU PJ 07; ZDV LQMHFWHG
LQWKUHHGRVHVPJHDFK7KHFKDUDFWHULVWLFVRIWKHDQDO\]HG
JURXSV LQ WHUPV RI WKH OHQJWK RI KRVSLWDOL]DWLRQ DJH %0,
REVWHWULF KLVWRU\ EK&* FRQFHQWUDWLRQV DV ZHOO DV V\PSWRPV
XSRQDGPLVVLRQDUHSUHVHQWHGLQ7DEOH,7KHGHFUHDVHRIEK&*
WRXQGHWHFWDEOHOHYHOVWRRNDSSUR[LPDWHO\GD\V
,QIRUPDWLRQ UHJDUGLQJ UHSURGXFWLYH SODQV DQG SRVVLEOH
SUHJQDQFLHVZDVREWDLQHGIURPSDWLHQWVGXULQJSDWLHQWIROORZ
XS YLVLWV WR WKH RXWSDWLHQW FOLQLF DV ZHOO DV WKURXJK WHOHSKRQH
FRQWDFW7KUHHPRQWKVLQWRWKH07;WUHDWPHQWSDWLHQWVGHFLGHG
to enroll into an in vitro Iertili]ation SroJraP anG oI tKeP JaYe EirtK to KealtK\ FKilGren 7KeVe SatientV Zere e[FlXGeG IroP IXrtKer VtXGieV 6XrJiFal SroFeGXreV Zere SerIorPeG in otKer SatientV GXrinJ 07; tKeraS\ anG tKeVe SatientV Zere not inFlXGeG in IXrtKer VtXGieV eitKer $PonJ tKe SatientV tKat TXali¿eG Ior IXrtKer VtatiVtiFal anal\ViV GiG not attePSt to FonFeiYe aJain ZKereaV SatientV attePSteG to FonFeiYe aJain anG oI tKeP JaYe EirtK to KealtK\ FKilGren 7Ke aYeraJe tiPe to SreJnanF\ ZaV PontKV 6' ZitK tKe ¿rVt anG tKe laVt SreJnanF\ oFFXrrinJ aIter anG PontKV reVSeFtiYel\ 7Ke FXPXlatiYe SreJnanF\ rate aIter a PontK oEVerYation SerioG SoVttreatPent iV illXVtrateG in )iJXre 1ot a VinJle FaVe oI FonJenital EirtK GeIeFtV eVSeFiall\ neXral tXEe or FarGiaF ZaV oEVerYeG 7Ke aYeraJe EirtK ZeiJKt ZaV J 6' $ reFXrrenFe oI eFtoSiF SreJnanF\ ZaV not oEVerYeG in tKe VtXG\
SoSXlation 7Ke FKaraFteriVtiFV oI SatientV ZKo JaYe EirtK aV Zell aV tKoVe ZKo GeVSite e[SeFtationV GiG not FonFeiYe are SreVenteG in 7aEle ,,
Discussion
0etKotre[ate rePainV to Ee tKe PoVt FoPPonl\ XVeG aV Zell aV tKe PoVt eIIeFtiYe PeGiFation in FonVerYatiYe PanaJePent oI eFtoSiF SreJnanF\ 7KiV antaJoniVt oI IoliF aFiG GiVrXStV '1$
V\ntKeViV anG inKiEitV Fell SroliIeration 7Ke raSiGl\ GiYiGinJ troSKoElaVtiF tiVVXe iV eVSeFiall\ VenVitiYe to itV eIIeFtV 07;
eIIeFt on otKer tiVVXeV VtronJl\ GeSenGV on tKe GoVe oI tKe GrXJ 7Ke PoVt FoPPonl\ enFoXntereG aGYerVe eIIeFtV oI 07; oYerGoVe inFlXGe inÀaPPation oI tKe PXFoVa oI tKe JaVtrointeVtinal traFt
Eone ParroZ VXSSreVVion FonMXnFtiYitiV KeSatoto[iFit\ anG SKotoVenVitiYit\ 6\VtePiF aGPiniVtration oI tKe PeGiFation Pa\
Ee XVeG in a Yariet\ oI VFKePeV ,n oXr VtXG\ a VinJle GoVe oI
PJ 07; ZitKoXt aGGitional IoliF aFiG VXSSlePentation
ZaV aGPiniVtereG ,n FaVeV ZitK inVXI¿Fient GroSV oI tKe EK&*
FonFentration aGGitional GoVeV oI 07; Zere JiYen
7Ke eI¿FaF\ oI FonVerYatiYe 07; treatPent ZaV
1oteZortK\ tKe treatPent ZaV eIIeFtiYe in SatientV ZitK KiJKer EK&* FonFentrationV Pa[iPal YalXe P,8Pl 7Ke nXPEer oI GoVeV oI 07; anG tKe total GoVe aGPiniVtereG are SreVenteG in 7aEle ,,, reVSeFtiYel\ 6XFK a KiJK SerFentaJe oI treatPent VXFFeVV enFoXraJeV SK\ViFianV to attePSt aGPiniVterinJ
Ta b l e I .
$JH\HDUV 30.0 ±4.8
%0, NJP 22.6 ± 3.1
1H[W SUHJQDQF\ )LUVW SUHJQDQF\ 47 54%
1H[W SUHJQDQF\ 39 46%
1XPEHU RI WKH FXUUHQW SUHJQDQF\
)LUVW 47 54%
6HFRQG 22 25.58%
7KLUG 13 15.11%
)RXUWK 1 1.16%
)LIWK 3 3.48%
1XPEHU RI SUHY. ' &
0 75 87.2%
1 9 10.46%
2 1 1.16%
4 1 1.16%
1XPEHU RI SUHY.
YDJLQDO GHOLYHULHV
0 71 82.55%
1 15 17.44%
1XPEHU RI SUHY.
FHVDUHDQ VHFWLRQV
0 76 88.37%
1 9 10.46%
2 1 1.16%
1XPEHU RI SUHY.
HFWRSLF SUHJQDQFLHV
0 76 88.37%
1 9 10.46%
2 1 1.16%
1XPEHU RI SUHY.
DERUWLRQV
0 67 77.9%
1 15 17.44%
2 2 2.32%
3 1 1.16%
4 1 1.16%
$EGRPLQDO SDLQ XSRQ DGPLVVLRQ 38 44.18%
9DJLQDO EOHHGLQJ XSRQ DGPLVVLRQ 67 77.9%
)UHH ÀXLG LQ WKH DEGRPHQ XSRQ
DGPLVVLRQ 25 29.06%
0HDQ WLPH RI KRVSLWDOL]DWLRQ GD\V 9.7 ± 5.2
0HDQ EK&* XSRQ DGPLVVLRQ P,8PO 3569.8 ± 4552.9
0HDQ EK&* PD[ P,8PO 4809.3 ± 6079.4
0HDQ EK&* RQ GLVFKDUJH P,8PO 2234.7 ± 3202.4 0HDQ GHFUHDVH RI EK&* RQ GLVFKDUJH
% 57.5 ± 25.1
Figure 1.
tKe PeGiFation in oXtSatient VettinJV ZKiFK ZoXlG ViJni¿Fantl\
FontriEXte to reGXFinJ KoVSitali]ation FoVtV 7KiV FoXrVe oI aFtion reTXireV SroSer traininJ oI tKe PeGiFal anG nXrVinJ VtaII at tKe oXtSatient FliniF aV Zell aV eVtaEliVKinJ VSeFi¿F Friteria reJarGinJ aGPiniVterinJ VXEVeTXent 07; GoVeV anG reFXrrent KoVSitali]ation ,t iV alVo neFeVVar\ to eGXFate SatientV anG tKeir IaPilieV Vo tKat tKe\ NnoZ KoZ to reaFt SroSerl\ in tKe FaVe oI ZorVeninJ FoPSlaintV
8nGer iGeal oSeratinJ FonGitionV a FXPXlatiYe SreJnanF\
rate ViPilar to tKe one IoXnG ZitK FonVerYatiYe 07; treatPent ZaV oEVerYeG 6XFK iGeal FonGitionV Fan oFFXr onl\ in FaVe oI PiFroVXrJiFal reanaVtoPoViV oI tKe IalloSian tXEeV aIter a Srior tXEal liJation ZKere tKe FXPXlatiYe SreJnanF\ rate inFlXGinJ eFtoSiF iV >@
,n tKe VtXG\ SoSXlation VXEMeFteG to 07; tKeraS\ eFtoSiF SreJnanFieV Zere not oEVerYeG 8nIortXnatel\ PiFroVXrJerieV oI tKe IalloSian tXEeV XVinJ tKe laSaroVFoSiF teFKniTXe KaYe a Àat learninJ FXrYe ZKiFK Pa\ reVXlt in an inVXI¿FienF\ oI KiJKl\
traineG VtaII PePEerV eVSeFiall\ GXrinJ ePerJenF\ VitXationV
)ertilit\ eYalXation in SatientV aIter FonVerYatiYe treatPent ZaV KiJKl\ VatiVIaFtor\ 'XrinJ KoVSitali]ation no VtatiVtiFal ViJni¿FanFe in tKe aPoXnt oI tKe aGPiniVtereG 07; ZaV oEVerYeG EetZeen SatientV ZitK an attePSteG IaileG FonFeStion anG SatientV ZitK a VXFFeVVIXl SreJnanF\ anG GeliYer\ $lVo tKere Zere no ViJni¿Fant GiIIerenFeV EetZeen tKe rate oI GeFreaVe oI tKe EK&*
FonFentration anG KoVSitali]ation lenJtK ± 3earVonV Forrelation FoeI¿Fient r ,t iV intereVtinJ to FonViGer eleYateG EK&*
FonFentrationV on tKe EorGer oI VtatiVtiFal ViJni¿FanFe p
in FaVe oI SatientV tKat VXFFeVVIXll\ FonFeiYeG 7KiV Pa\ Ee GXe to Jreater ElooG ÀoZ in tKe reJion oI tKe eFtoSiF SreJnanF\ tKXV IaFilitatinJ GrXJ aEVorStion into tKe tarJet tiVVXe
7Ke SreVenFe oI V\PStoPV XSon aGPiVVion ZaV on tKe EorGer oI ViJni¿FanFe p ± ie aEGoPinal Sain anG YaJinal EleeGinJ ZKiFK ZaV Pore IreTXent in SatientV aEle to FonFeiYe VSontaneoXVl\ aIter tKe treatPent :e VXVSeFt tKat one oI tKe Pain IaFtorV in PaintaininJ IXrtKer Iertilit\ iV loFali]ation oI tKe eFtoSiF SreJnanF\ 6eYere ViJnV anG V\PStoPV Pa\ VXJJeVt an intraPXral VeFtion oI tKe IalloSian tXEe $ltKoXJK a Jreater intenVit\ oI V\PStoPV PaNeV tKe GeFiVion Ior FonVerYatiYe treatPent Pore GiI¿FXlt 07; treatPent rePainV to Ee Eene¿Fial
It is worth to mention the emotional trauma which accomSanies the GiaJnosis oI an ectoSic SreJnanc\ 7he GiaJnosis
anG the IollowinJ JrieI ma\ haYe an imSact on the se[ualit\ oI the couSle $s conserYatiYe treatment is more time consuminJ
Satients shoulG Ee oIIereG 7enGer /oYinJ &are 7/&
6tuGies haYe shown that 7/& ma\ haYe a siJni¿cant imSact on the chance oI a liYe Eirth rate in the ne[t SreJnanc\ >@ :e
¿nG the SersSectiYe oI reJaininJ Iertilit\ esSeciall\ imSortant to these couSles
Ta b l e I I .
SUHJQDQW
QRWSUHJQDQW QXPEHURI
SDWLHQWV PHDQ SD PLQ PD[ SYDOXH
+RVSLWDOL]DWLRQ WLPH GD\V 1 15 11.7 4.1 6 18
0.06
2 10 8.4 3.7 4 15
)LUVW EK&* ,8PO 1 16 3185.6 2688.7 58 8414
0.12
2 10 1478 1261.6 76 3937
0D[ EK&* ,8PO 1 16 4404.6 3855.7 58 3425.5
2 10 1920.4 2194.6 118 1259 0.06
EK&* RQ GLVFKDUJH ,8PO 1 15 2011.9 1638 17 5279
0.08
2 10 1072.4 1715.6 38 5772
'HFUHDVH RI EK&* RQ GLVFKDUJH %
1 15 55.4 22.9 23.4 96.1
2 10 52.4 20.3 21.3 87.8 0.85
%0, NJP2 1 16 22.4 2.3 19.6 26.2
0.79
2 10 22.8 4.4 18 29.2
DJH \HDUV 1 16 28.9 4.6 22 39
0.17
2 10 31.4 4.5 30 40
Ta b l e I I I .
DRVHRI
0HWKRWUH[DWH
LP
QXPEHURI
07;GRVDJHV QXPEHURI
SDWLHQWV SHUFHQWDJHRI
SDWLHQWV
50 PJ 1 6 7.0%
100 PJ 2 19 22.1%
150 PJ 3 42 48.8%
200PJ 4 6 7.0%
It is also Yital to note that 07; theraS\ is the treatment oI choice in cases oI uniTue locali]ations oI an ectoSic SreJnanc\
such as cerYical anG uterine scar SreJnancies )inall\ in uncertain cases eIIort shoulG Ee unGertaNen to aYoiG ethical conseTuences oI the wronJ GiaJnosis anG Gecision
Conclusions
6\stemic conserYatiYe manaJement with methotre[ate is an eIIectiYe anG saIe Iorm oI treatinJ an ectoSic SreJnanc\ eYen in cases where Eh&* concentrations are Jreater than mI8
ml 7he maMorit\ oI Satients can Ee successIull\ treateG without surJer\ anG thereIore ma\ eYen Ee treateG in outSatient settinJs
+iJh Iertilit\ inGeSenGent oI the sNills oI the oSerators anG access to laSaroscoSic techniTues can Ee maintaineG
&onserYatiYe treatment Goes not increase the risN oI GeYeloSinJ a recurrent ectoSic SreJnanc\ 7reatment shoulG Ee oIIereG in warGs that SroYiGe hour surJical care
Oświadczenie autorów
1. Jakub Wyroba – autor koncepcji i założeń pracy, przygotowanie manuskryptu i piśmiennictwa – autor zgłaszający i odpowiedzialny za manuskrypt.
2. Józef Krzysiek – autor założeń pracy, współautor protokołu, ostateczna weryfikacja i akceptacja manuskryptu.
3. Agnieszka Rajtar-Ciosek – opieka kliniczna, analiza statystyczna wyników, przygotowanie manuskryptu.
4. Olga Kacalska-Janssen – opracowanie koncepcji i założeń badań, opracowanie wyników badań, opieka kliniczna.
5. Andrzej Zmaczyński – analiza i interpretacja wyników, przygotowanie, korekta kształtu manuskryptu.
6. Joanna Wiatr – opracowanie wyników badań, przechowywanie dokumentacji.
7. Tomasz Milewicz – zebranie materiału, opieka kliniczna.
8. Magdalena Pulka – współautor tekstu pracy, korekta i aktualizacja literatury.
Źródło finansowania:
Praca nie była finansowana przez żadną instytucję naukowo-badawczą, stowarzyszenie ani inny podmiot, autorzy nie otrzymali żadnego grantu.
Konflikt interesów:
Autorzy nie zgłaszają konfliktu interesów oraz nie otrzymali żadnego wynagrodzenia związanego z powstawaniem pracy.
References
1. Ectopic pregnancy rates in the Medicat population. (PIMD 23313717).
2. Center for Disease Control and Prevention (CDC) Ectopic pregnancy - United States, 1990- 1992. MMWR Morb Mortal Wkly Rep. 1995, 45 (4), 46-48.
3. Seeber BE, Barnhart KT. Suspected ectopic pregnancy. Obstet Gynecol, 2006, 107 (2Pt1), 399-413.
4. Stamatopulos N, Casikar I, Reid S, [et al.]. Chlamydia trachomatis in fallopian tubes of women undergoing laparoscopy for ectopic pregnancy. Aust NZJ Obstet Gynaecol. 2012, 52, 377-379.
5. Zenilman JM. Genital Chlamydia trachomatis infections in women, 2011. [Accessed Jan 2011] Available from URL http://www.uptodate.com/contents/genital-chlamydia-trachomatis- infection-in-women.
6. Pientong C, Ekalaksananan T, Wonglikitpanya N, [et al.]. Chlamydia trachomatis infections and the risk of ectopic pregnancy in Khon Kaen women. J Obstet Gynaecol Res. 2009, 35 (4), 775- 781.
7. Naderi T, Kazerani F, Bahrampoor A. Comparison of Chlamydia infection prevalence between patients with and without ectopic pregnancy using the PCR method. Ginekol Pol. 2012, 83 (11), 819-821.
8. Kirk E, Papageorghiou AT, Condous G, [et al.]. The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancy. Hum Reprod. 2007, 22 (11), 2824-2828.
9. Casikar I, Reid S, Condous G. Ectopic pregnancy: Ultrasound diagnosis in modern management.
Clin Obstet Gynecol. 2012, 55 (2), 402-409.
10. Glass RH, Jesurun HM. Immunologic pregnancy tests in ectopic pregnancy. Obstet Gynecol.
1966, 27 (1), 66-68
11. Kadar N, Caldwell BV, Romero R. A method of screening for ectopic pregnancy and its indications. Obstet Gynecol. 1981, 58 (2), 162-166.
12. Harbert WW. A case of extra uterine pregnancy. West J Med Surg. 1849, 3, 110.
13. Chotiner HC. Nonsurgical management of ectopic pregnancy associated with severe hyperstimulation syndrome. Obstet Gynecol. 1985, 66 (5|), 740-743.
14. Montesinos MC, Takedachi M, Thompson LF, [et al.]. The Antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto- 5-nucleotidase. Artritis Rheum. 2007, 56 (5), 1440-1445.
15. Hajenius PJ, Mol BWJ, Bossuyt PMM, [et al.]. Interventions for tubal ectopic pregnancy. The Cochrane Library 2006, Issue 4.
16. Duenas-Garcia OF, Young C, Mikhail M, Salafia C. Compliance with follow-up in an inner-city population treated with intramuscular methotrexate for suspected ectopic pregnancy. Int J Gynecol Obstet. 2013, 120 (3), 254-256.
17. Pektasides D, Rustin GJ, Newlands ES, [et al.]. Fertility after chemotherapy for ovarian germ cell tumours. Br J Obstet Gynaecol. 1987, 94 (5), 477-479.
18. Ayhan A, Ergeneli MH, Yüce K, [et al.]. Pregnancy after chemotherapy for gestational trophoblastic disease. J Reprod Med. 1990, 35 (5), 522.
19. Keefe KA, Wald JS, Goldstein DP, [et al.]. Reproductive outcome after methotrexate treatment of tubal pregnancies. J Reprod Med. 1998, 43 (1), 28-32.
20. Kung FT, Chang SY, Tsai YC, [et al.]. Subsequent reproduction and obstetric outcome after methotrexate treatment of cervical pregnancy: a review of original literature and international collaborative follow-up. Hum Reprod. 1997, 12 (3), 591-595.
21. Oriol B, Barrio A, Pacheco A, [et al.]. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril. 2008, 90 (5), 1579-1582.
22. Tulandi T. Reproductive performance of women after two tubal ectopic pregnancies. Fertil Steril.
1988, 50 (1), 164-166.
23. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986, 1 (2), 81-87.
24. Strauss, JF, Williams, CJ. The ovarian life cycle. In: Yen and Jaffe’s Reproductive Endocrinology:
Physiology, Pathophysiology, and Clinical Management. 5th ed. Strauss, JF, Barbieri, RL (Eds).
Philadelphia: Elsevier Saunders, 2004. 213.
25. Svirsky R, Rozovski U, Vaknin Z, [et al.]. The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy. Reprod Toxicol. 2009, 27 (10), 85-87.
26. Sreshthaputra O, Streshtapura RA, Vutyavanich T. Factors affecting pregnancy rates after microsurgical reversal of tubal sterilization. J Reconstr Microsurg. 2013, 29 (3), 189-194.
27. Lachmi-Epstein A, Mazor M, Bashiri A. Psychological and mental aspects and “tender loving care” among women with recurrent pregnancy losses. Harefuah. 2012, 151 (11), 633-637, 654.